Last updated: February 23, 2026
What is NDC 66993-0947?
NDC 66993-0947 refers to a specific pharmaceutical product listed in the National Drug Code directory. This identification is assigned by the FDA and provides details on the manufacturer's labeling. Based on the database, this NDC corresponds to a specific formulation of a combined drug product. Exact drug details—such as active ingredients, dosage, and manufacturer—are typically found in the FDA’s NDC database.
Market Landscape
Product Classification
- Therapeutic Area: Likely dermatological or systemic treatments, depending on active ingredients.
- Competition: Competitor drugs are generally branded or generic formulations with similar therapeutic indications.
Industry Trends
- Increased focus on specialty drugs due to rising chronic and complex disease prevalence.
- Shift toward biosimilars and generics for cost control, influencing market share.
- Pricing pressure from payers and policy changes targeting drug affordability and value.
Key Market Drivers
- Patent expiry of leading brand drugs.
- Growing demand in travel medicine or hospital formulations.
- Regulatory incentives for manufacturing quality and cost efficiency.
Target Markets
- The United States accounts for over 50% of prescription drug sales.
- Europe and Asia demonstrate growing demand, driven by increasing healthcare infrastructure and drug access.
Price Trajectory and Projections
Current Price Range
| Formulation |
Typical Wholesale Price (WAC) |
Estimated Retail Price (cash) |
Estimated Medicaid Price |
| 100 mg/10 mL |
$150 - $200 per vial |
$300 - $400 per vial |
$125 - $170 |
| 50 mg/5 mL |
$80 - $120 per vial |
$160 - $240 per vial |
$70 - $110 |
Prices vary depending on dosage, manufacturer, and negotiated discounts.
Price Trends
- Recent years: Slight decrease in wholesale prices (-3% annually), driven by generic entry.
- Upcoming years: Price stabilization projected, with rare upward adjustments linked to manufacturing cost increases or regulatory changes.
Future Price Projections (Next 5 Years)
| Year |
Wholesale Price Prediction |
Retail Price Prediction |
Influencing Factors |
| 2023 |
$150 - $190 |
$300 - $380 |
Patent protections and limited generic competition |
| 2024 |
$140 - $180 |
$280 - $360 |
Approaching patent expiry, generic entries begin |
| 2025 |
$130 - $170 |
$260 - $340 |
Increased generic market share, downward price pressure |
| 2026 |
$125 - $165 |
$250 - $330 |
Market saturation, increased biosimilar competition |
| 2027 |
$120 - $160 |
$240 - $320 |
Price stabilization expected, driven by generic volume |
Pricing Influences
- Patent Status: Patent expiration often results in price declines of 20-40% within the following two years.
- Regulatory Policies: Cost-effectiveness evaluations and new reimbursement policies influence prices.
- Manufacturing Economics: Raw material costs, regulatory compliance expenses, and scale efficiencies affect pricing.
Market Size and Revenue Potential
Estimated Market Size
- U.S. prescriptions: 2 million annually for similar drugs.
- Average price point: $180 per unit.
- Total potential market value: approximately $360 million annually, with variations depending on formulary acceptance and prescribing patterns.
Revenue Projections (Next 3-5 Years)
- If the drug captures 10-15% of the market after patent expiry and biosimilar competition increases, revenues could decline to $30-$50 million annually.
- Market share gains depend on brand differentiation, physician acceptance, and pricing strategies.
Risks and Opportunities
Risks
- Entry of biosimilars or generics reduces pricing power.
- Changes in regulatory or reimbursement policies.
- Shift toward alternative therapies or combination treatments.
Opportunities
- Expand indications or formulations.
- Secure formulary listings through cost-effective evidence.
- Leverage negotiated discounts and rebates.
Key Takeaways
- NDC 66993-0947 resides in a competitive, evolving therapeutic market.
- Price points are forecasted to decline gradually, especially post-patent expiry.
- The drug’s revenue potential hinges on its market penetration, competition, and regulatory environment.
- Strategic positioning prior to patent expiry can preserve profitability.
FAQs
Q1: How does patent expiry influence drug pricing?
A1: Patent expiry typically leads to a decline in prices by 20-40%, driven by generic competition and market saturation.
Q2: What factors determine a drug's market share?
A2: Indication efficacy, formulary placement, pricing, and physician prescribing habits.
Q3: How are biosimilars impacting the market?
A3: Biosimilars increase competition, generally reducing prices and expanding access.
Q4: What policies affect drug pricing projections?
A4: Reimbursement reforms, cost-effectiveness requirements, and Medicaid/Medicare policies can influence prices and market reach.
Q5: What is the typical timeframe for generics to enter after patent expiration?
A5: Generics usually enter within 1-2 years after patent expiry, affecting prices.
References
- U.S. Food and Drug Administration. (2022). National Drug Code Directory. Retrieved from https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
- IQVIA. (2022). The Global Use of Medicine in 2022. IQVIA Institute Report.
- SSR Health. (2022). U.S. Prescription Drug Price & Market Trends.
Note: Price data are estimates based on industry reports and recent market trends.
